Impact of Obicetrapib on Major Adverse Cardiovascular Events in High-Risk Patients
Stephen J. Nicholls, Adam J. Nelson, Kausik K. Ray, Christie M. Ballantyne, Marc Ditmarsch, Douglas Kling, Andrew Hsieh, Michael Szarek, John J.P. Kastelein, Michael H. Davidson
Topics & Concepts
MedicineAdverse effectIntensive care medicineInternal medicineCardiologyLipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and LipoproteinsAntiplatelet Therapy and Cardiovascular Diseases